MUMBAI, India, Dec. 14 /PRNewswire-FirstCall/ -- One of India's premier cancer centers is acquiring the country's first Trilogy® machine from Varian Medical Systems (NYSE: VAR) to offer patients the most advanced radiotherapy treatments in the world. The Trilogy medical linear accelerator will be installed at Tata Memorial Hospital in Mumbai late next year.
Using the Trilogy accelerator, doctors at Tata Memorial Hospital will be able to offer cancer patients more precise treatments, including image-guided radiotherapy (IGRT) as well as stereotactic radiosurgery (SRS) for controlling and stopping early stage metastatic cancers.
Dr. Shyam Kishore Shrivastava, head of Department of Radiation Oncology at Tata Memorial Hospital, said, "We wish to treat our patients with the most modern and effective techniques available, which is why we have chosen the Trilogy. This will enable us to offer image-guided radiotherapy treatments with our first On-Board Imager and this is something of which we're particularly proud." The On-Board Imager® makes it possible to target tumors more accurately by taking X-ray images of them at the time of treatment.
Fritz Derrer, Varian's regional sales director, says, "Tata Memorial Hospital is known for its pioneering approach to cancer treatments and this decision to order a Trilogy demonstrates its desire to offer the most comprehensive and effective cancer treatments to patients."
The hospital, which registers 30,000 new patients each year from India and neighboring countries, is currently equipped with three Varian Clinac® linear accelerators. The arrival of the Trilogy accelerator will mean they can care for more patients in addition to offering more advanced treatments. The hospital plans to extend its intensity modulated radiotherapy (IMRT) program which enables staff to concentrate treatment doses on tumors while protecting more surrounding healthy tissue.
A fully-accessorized Trilogy medical linear accelerator, equipped with Varian's On-Board Imager for fast and effective image-guidance, is capable of offering all standard radiation therapies as well as advanced treatments such as IMRT, IGRT and SRS. It is expected to help doctors to improve cure rates for patients while reducing treatment complications.
Since its launch in 2004, Trilogy devices have been installed in numerous hospitals around the world, including leading oncology centers in Malaysia, Taiwan and Australia as well as several top US and European cancer hospitals.
Editorial contact: Neil Madle, Varian Medical Systems, +44-7786-526068, firstname.lastname@example.org
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California is the world's leading manufacturer of medical products for treating cancer and other medical conditions with radiotherapy, brachytherapy, and radiosurgery. The company is also a premier supplier of X-ray tubes and digital detectors for imaging in medical, scientific, and industrial applications. Varian Medical Systems employs approximately 3,900 people who are located at manufacturing sites in North America and Europe and in its 56 sales and support offices around the world. In Europe, the company operates manufacturing and engineering centers in Baden (Switzerland), Crawley (England), Haan (Germany), Helsinki (Finland) and Toulouse (France) and has headquarters for Europe, Middle East, India and Africa (EMEA) based in Zug, Switzerland. Additional information is available on the company's web site at http://www.varian.com/
Forward Looking Statements
Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "can" and "expect," constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.
SOURCE: Varian Medical Systems, Inc.
CONTACT: media, Neil Madle of Varian Medical Systems, +44-7786-526068,
Web site: http://www.varian.com/